Free shipping on all orders over $ 500

Ro 363 hydrochloride

Cat. No. M58543

All AbMole products are for research use only, cannot be used for human consumption.

Ro 363 hydrochloride Structure
Synonym:

Ro 363 HCl

Price and Availability

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

Ro 363 hydrochloride is a potent and highly selective β1-adrenoceptor agonist. Ro 363 hydrochloride is also an effective inotropic stimulant. Ro 363 hydrochloride is a cardiovascular modulator that reduces diastolic blood pressure and pronounces increases in myocardial contractility.

Chemical Information
Molecular Weight 399.87
Formula C19H26ClNO6
CAS Number 250580-70-2
Form Solid
Solubility (25°C) DMSO 95 mg/mL
Water 45 mg/mL
Storage 4°C, sealed
Related Adrenergic Receptor Products
Tamsulosin hydrochloride

Tamsulosin is a new, highly selective α1A-adrenoceptor antagonist.

Mirabegron

Mirabegron (YM178) is a potent and selective β(3)-adrenoceptor agonist with EC50 of 22.4 nM.

Detomidine hydrochloride

Detomidine hydrochloride is a nonnarcotic, synthetic alpha-2 adrenoreceptor agonist.

(R)-(+)-Atenolol

(R)-(+)-Atenolol binds to but does not activate beta-adrenergic receptors thereby blocking the actions of endogenous or exogenous beta-adrenergic agonists.

Reboxetine mesylate

Reboxetine mesylate is a potent and selective inhibitor of noradrenalin uptake (Ki values are 1.1, 129 and > 10000 nM for rat NET, SERT and DAT respectively).

  Catalog
Abmole Inhibitor Catalog




Keywords: Ro 363 hydrochloride, Ro 363 HCl supplier, Adrenergic Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.